Stock CMLT CM LIFE
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News CM LIFE

Equities

CMLT

US1258411065

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CM Life Sciences III : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K
PU
Drug Firm EQRx to Make Nasdaq Debut Monday After Merger Deal With Blank Check Company
MT
CM Life Sciences III : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
CM LIFE SCIENCES III INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
CM Life Sciences III Inc.(NasdaqCM:CMLT) dropped from NASDAQ Composite Index
CI
EQRx, Inc. completed the acquisition of CM Life Sciences III Inc. from CMLS Holdings III LLC and others in a reverse merger transaction.
CI
EQRx and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination
BU
EQRx, Inc. and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination
CI
EQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference
BU
CM LIFE SCIENCES III INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
AQ
CM LIFE SCIENCES III INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in Middle East, Turkey and Africa
BU
EQRx Launches “Remaking Medicine: On The Record” Investor Video Series
BU
CM LIFE SCIENCES III INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
CM LIFE SCIENCES III INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
CM Life Sciences III : EQRx to Collaborate With England's National Health Service Over Cheaper Cancer Medicines
MT
EQRx : and NHSE Sign Memorandum of Understanding to Enter into England’s First Population Health Partnership for Cancer Drugs
BU
Certain Class B Common Stock of CM Life Sciences III Inc. are subject to a Lock-Up Agreement Ending on 4-OCT-2021.
CI
EQRx : Appoints Kathy Giusti to Board of Directors
BU
EQRx : Announces Presentation of Phase 3 Data Demonstrating a Progression-Free Survival Benefit with Sugemalimab Consolidation Therapy in Patients with Stage III NSCLC at ESMO Congress 2021
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CMLT Stock
  4. News CM LIFE